Repurposing Clinical Drugs as AdoMetDC Inhibitors Using the SCAR Strategy

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00248
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures

Frontiers in Immunology
AllergyImmunology
2019English

A Repurposing Strategy for Hsp90 Inhibitors Demonstrates Their Potency Against Filarial Nematodes

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2014English

ReDO_DB: The Repurposing Drugs in Oncology Database

ecancermedicalscience
Cancer ResearchOncology
2018English

Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria

English

Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza a Virus Replication

Assay and Drug Development Technologies
Drug DiscoveryMolecular Medicine
2015English

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs as Cancer Therapeutics

Frontiers in Oncology
Cancer ResearchOncology
2017English

Repurposing Old Drugs to Chemoprevention: The Case of Metformin

Seminars in Oncology
OncologyHematology
2016English

Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection

Frontiers in Microbiology
Microbiology
2015English

Repurposing as a Strategy for the Discovery of New Anti-Leishmanials: The-State-Of-The-Art

Parasitology
Animal ScienceZoologyParasitologyInfectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy